Home – CV Transforum Spring’25
CV Transforum is a cardiovascular conference offering deep-dives into key trends and issues as leaders transform cardiovascular care together.
CV Transforum is a cardiovascular conference offering deep-dives into key trends and issues as leaders transform cardiovascular care together.
View all access and purchase options for this article. 1. Ogino H, Iida O, Akutsu K, et al.; Japanese Circulation Society, the Japanese Society for…
Go Red for Women is the American Heart Association’s national movement to end heart disease and stroke in women. Learn more, get involved, and take…
Pulmonary vein isolation (PVI) by pulsed-field ablation (PFA) has demonstrated encouraging clinical results for the treatment of atrial fibrillation (AF).1,2 Whereas the ability of other…
Atrial fibrillation (AF) is a relatively prevalent arrhythmia in patients with kidney failure requiring dialysis, who face a high risk of stroke and bleeding, and…
Limited evidence supports apixaban’s use for atrial fibrillation (Af) in severe chronic kidney disease (CKD) or end-stage kidney disease (ESKD) patients, where warfarin is often…
Abstract Submission is Now Open! Submit your abstract here. Key Dates October 2023 Abstract submission opens. January 24, 2024 Deadline for abstract submission and editing…
Researchers shared new studies on the highly selective CETP inhibitor in The New England Journal of Medicine and The Lancet.
DALLAS, May 7, 2025 — One in eight U.S. households struggles to access enough food, and that number is on the rise.[1] The American Heart…
Jake Chapman was eating when his heart stopped. His dad started CPR while his mom called 911. Their quick actions saved their son’s life.
Abstracts & Cases. Discussion, debate, diversity, innovation and review – HRC, the word in education in arrhythmias.